packageLinvoseltamab

linvoseltamab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Linvoseltamab is an anti-cancer monoclonal antibody used to treat multiple myeloma. It is authorised in the European Union and remains under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q133445837 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:linvoseltamab
ATC codes:L01FX37
DrugBank:DB17447
Wikidata:Q133445837

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown